Clinical Trials on Alpers Syndrome
Total 35056 results
-
University of WaterlooAlcon ResearchCompleted
-
Dong-A ST Co., Ltd.CompletedDry Eye SyndromeKorea, Republic of
-
Alcon ResearchCompleted
-
University of Campinas, BrazilMerck Sharp & Dohme LLCCompleted
-
AllerganCompletedDry Eye SyndromesUnited States
-
AllerganCompleted
-
Wuhan Union Hospital, ChinaNot yet recruitingMyelodysplastic Syndromes
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingHemophagocytic Syndromes
-
Otsuka Beijing Research InstituteRecruitingMyelodysplastic SyndromesChina
-
Bristol-Myers SquibbRecruitingMyelodysplastic SyndromesSpain, United States, France, Italy, Belgium, Germany, Poland, Czechia, Puerto Rico
-
Peking Union Medical College HospitalNot yet recruitingMyelodysplastic SyndromesChina
-
University Hospital, GrenobleRecruiting
-
Novartis PharmaceuticalsRecruitingMyelodysplastic SyndromesJapan
-
H. Lee Moffitt Cancer Center and Research InstituteNovartis PharmaceuticalsRecruitingMyelodysplastic SyndromesUnited States
-
Novartis PharmaceuticalsTerminatedMyelodysplastic SyndromesUnited States, Spain, Italy, Singapore, Korea, Republic of, Israel, Australia
-
Bristol-Myers SquibbActive, not recruitingMyelodysplastic SyndromesArgentina, Canada, France, Germany, Italy, Korea, Republic of, Poland, United States, Australia, China, Czechia, Denmark, Greece, Hong Kong, Japan, Spain, Sweden
-
University Hospital, GrenobleActive, not recruiting
-
Asan Medical CenterActive, not recruiting
-
Asan Medical CenterCompletedMyelodysplastic SyndromesKorea, Republic of
-
Thomas Jefferson UniversityWithdrawnMyelodysplastic SyndromesUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI); Alliance for Cancer Gene TherapyTerminatedMyelodysplastic SyndromesUnited States
-
Janssen Research & Development, LLCCompletedMyelodysplastic SyndromesUnited States, Belgium, Italy, Spain, Netherlands, Russian Federation
-
SymBio PharmaceuticalsCompleted
-
SymBio PharmaceuticalsCompleted
-
SymBio PharmaceuticalsWithdrawnMyelodysplastic SyndromeJapan
-
The University of Hong KongActive, not recruiting
-
Groupe Francophone des MyelodysplasiesCompleted
-
Helsinn Healthcare SATerminatedMyelodysplastic SyndromesUnited States
-
Acceleron Pharma Inc. (a wholly owned subsidiary...Completed
-
Grupo Cooperativo de Estudio y Tratamiento de las...Celgene Corporation; Germans Trias i Pujol Hospital; Hospital Son LlatzerUnknown
-
Samsung Medical CenterCompletedMyelodysplastic SyndromeKorea, Republic of
-
University Hospital, ToulouseNational Cancer Institute, FranceCompleted
-
Hoffmann-La RocheCompletedMyelodysplastic SyndromesThailand
-
CelgeneTerminatedMyelodysplastic SyndromeUnited States
-
CelgeneCompleted
-
CelgeneCompletedMyelodysplastic SyndromesItaly, United Kingdom, Germany, Australia, Bulgaria, France, Greece, Hungary, Netherlands, Poland, Spain
-
CelgeneCompleted
-
CelgeneCompletedMyelodysplastic SyndromeUnited States
-
Hoffmann-La RocheCompletedMyelodysplastic SyndromesUnited States
-
University of FloridaGateway for Cancer Research; Cellworks Group Inc.WithdrawniCare 2: Personalized Genomic Mutation Informed Treatment of Patients With Myelodysplastic SyndromesMyelodysplastic SyndromesUnited States
-
Masonic Cancer Center, University of MinnesotaMayo ClinicCompletedMyelodysplastic SyndromeUnited States
-
Lixte Biotechnology Holdings, Inc.UnknownMyelodysplastic SyndromesUnited States
-
Weill Medical College of Cornell UniversitySunesis PharmaceuticalsCompletedVosaroxin for Intermediate 2 or High-risk MDS After Failure With Hypomethylating Agent-based TherapyMyelodysplastic SyndromeUnited States
-
Seagen Inc.TerminatedMyelodysplastic SyndromeUnited States
-
Associazione Qol-oneTerminatedMyelodysplastic SyndromesFrance, Italy, Greece
-
Helsinn Healthcare SACompletedMyelodysplastic SyndromeUnited States
-
Novartis PharmaceuticalsTerminated
-
Boehringer IngelheimTerminatedMyelodysplastic SyndromesJapan